Description: GeneDx Holdings Corp., a genomics company, provides personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company accelerate the use of genomics and leverage clinical data to enable precision medicine as the standard of care. It utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients. The company offers genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Home Page: www.genedx.com
North Tower
Stamford,
CT
06902
United States
Phone:
888 729 1206
Officers
| Name | Title |
|---|---|
| Ms. Katherine A. Stueland | President, CEO & Director |
| Mr. Kevin Feeley CPA | Chief Financial Officer |
| Ms. Karen Ponchner | Head of Operations |
| Mr. Eric Olivares Ph.D. | Chief Product & Technology Officer |
| Ms. Heidi C. Chen J.D. | Chief Legal Officer |
| Ms. Jami Biliboaca | Head of People Strategy |
| Mr. Paul Kruszka FACMG, M.D., M.P.H. | Chief Medical Officer |
| Ms. Melanie Duquette | Chief Growth Officer |
| Sabrina Dunbar | Chief of Staff |
| Ms. Britt Johnson | Head of Medical Affairs |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.6411 |
| Price-to-Sales TTM: | 7.5898 |
| IPO Date: | 2020-11-04 |
| Fiscal Year End: | December |
| Full Time Employees: | 1000 |